AI주식인사이트AI Stock Insight
C

플라즈맵

405000KOSDAQ의료용 기기 제조업

47.3 / 100

Reference Date: 2026-06-10

Financial Score7.0 / 40
News Sentiment21.3 / 25
Momentum7.0 / 20
Disclosure12.0 / 15
AI Analysis: the high debt ratio poses financial risk, ROE is below the industry average. Plunged 41.8% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Plazmap is a plasma technology company founded in 2015 by KAIST alumni, specializing in bio-plasma applications for the medical device market. Key products include STERLINK (a low-temperature sterilizer using biological inactivation), ACTILINK (a surface activation device for implants using regenerative activation), and CARELINK (a stimulative therapy device for periodontal treatment). The company has achieved global market expansion, including FDA certification in the U.S.

Number of Employees

46people

Average Salary

63.7M KRW

Score Calculation Basis

Detailed Financial Score

PER
—Industry Average 21.514.0Point
PBR
2.90Industry Average 1.380.0Point

2.1x industry avg (risky)

ROE
-128.57Industry Average 8.000.0Point

Well below industry avg

Debt Ratio
34.27Industry Average 11.650.0Point

2.9x industry avg (risky)

Trend 2023~20253.0 / 10 points
Revenue Growth Rate
0.0 / 3

Avg ▼18.9% (2-year basis)

Operating Profit Growth Rate
3.0 / 3

Avg ▲35.6% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -224.6% (improving, 3yr)

Detailed News Sentiment

1 totalPositive 1Neutral 0Negative 0Average Sentiment Score 85

Detailed Momentum

52-week position1.0Point

Near 52w low (0%, downtrend)

Current 4,325Won52-week high 9,50052-week low 4,325
1-month return0.0Point

1m -41.79% (strong drop)

Volume trend6.0Point

Volume surge

Detailed Disclosure

4 totalPositive 1Neutral 3Negative 0
  • Positive단일판매ㆍ공급계약체결2026-06-04
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-06-02
  • Neutral주식등의대량보유상황보고서(일반)2026-06-02
  • Neutral분기보고서 (2026.03)2026-05-15